Related Experiment Video

Updated: May 12, 2026

Prediction of HIV-1 Coreceptor Usage (Tropism) by Sequence Analysis using a Genotypic Approach
07:06

Prediction of HIV-1 Coreceptor Usage (Tropism) by Sequence Analysis using a Genotypic Approach

Published on: December 1, 2011

Predictors of Chronic Hepatitis C Evolution in HIV Co-Infected Patients From Romania

Camelia Sultana1, Simona Manuela Erscoiu, Camelia Grancea

  • 1Department of Virology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania ; Emergent Disease Department, Stefan S. Nicolau Institute of Virology, Bucharest, Romania.

Hepatitis Monthly
|April 25, 2013
PubMed

Insights

In Romania, many HIV-HCV co-infected patients show poor liver disease predictors. High IP-10 levels indicate severe liver disease, requiring careful management in these patients.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Immunology

Background:

  • Increasing rates of HIV-HCV co-infection in Romania necessitate research into disease progression.
  • Understanding baseline predictors is crucial for managing liver disease in co-infected individuals.

Purpose of the Study:

  • To assess baseline predictors of liver disease progression in HIV-HCV co-infected patients in Romania.
  • To evaluate the role of viral load, liver fibrosis (FIB-4), and IP-10 in disease evolution.

Main Methods:

  • Cross-sectional study of 83 treatment-naïve HCV patients co-infected with HIV.
  • Assessed HCV viral load, FIB-4 for liver fibrosis, and plasma IP-10 levels.
  • Correlated these markers with immunosuppression, viral replication, and treatment status.

Main Results:

  • High HCV viral load (median 6.3 log10 IU/mL) and HCV genotype 1 infection were prevalent.
  • Severe fibrosis correlated with immunosuppression, higher HCV replication, and elevated IP-10.
  • High serum IP-10 (>400 pg/mL) associated with advanced liver fibrosis (FIB-4), higher HCV viral load, and elevated ALT.

Conclusions:

  • Many HIV-HCV co-infected patients present with negative predictors for HCV progression.
  • Plasma IP-10 is a reliable marker for assessing liver disease severity in co-infected patients.
  • Therapeutic management requires attention to adherence and potential drug toxicities.
Abstract

Keywords:
Biological MarkersCoinfectionRomania

More Related Videos

A Protocol for Analyzing Hepatitis C Virus Replication13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...